Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Report Overview
The urinary incontinence drugs market was valued at USD 2170.44 Million in 2025, driven by growing aging population and increasing awareness and diagnosis rates of urinary incontinence expenditure across the 8 major markets. The market is anticipated to grow at a CAGR of 7.00% during the forecast period of 2026-2035, with the values likely to reach USD 4269.58 Million by 2035. The market is driven by the increasing elderly population and the introduction of advanced drug formulations with improved efficacy and fewer side effects. Rising healthcare spending and expanding reimbursement policies are also expected to support market value during the forecast period.
Key Market Trends and Insights
- Stress incontinence held the largest share of around 30.03% during the historical period.
- Anticholinergics dominate the market by drug type.
- The female segment leads the market by gender, reflecting higher prevalence and treatment rates.
- Hospital pharmacies represent the leading distribution channel in the market.
Market Size and Forecast
- Market Size (2025): USD 2170.44 Million
- Projected Market Size (2035): USD 4269.58 Million
- CAGR (2026-2035): 7.00%
- Largest Market in 2025: United States
2025
Base Year
2019-2025
Historical Period
2026-2035
Forecast Period
-
Bladder and continence issues affect an estimated 1 in 5 people in the UK, with 14 million affected, according to NHS . This rising prevalence significantly fuels demand for urinary incontinence drugs across global markets.
-
In April 2024, Zydus launched generic Mirabegron Extended-Release Tablets in the U.S., expanding access to affordable treatment for overactive bladder with symptoms of urge urinary incontinence. This strategic entry is expected to positively influence market growth across key regions.
-
A key trend in the urinary incontinence drugs market is the shift toward device-based and mRNA therapies. For instance, in 2024, UroMems reported positive trial results for its UroActive implant using MyoElectroMechanical technology.
Urinary Incontinence Drugs Market: Competitor Landscape
The key features of the market report comprise clinical trials analysis, patent analysis, grant analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Pfizer, Inc.
Pfizer Inc., a leading global biopharmaceutical company, actively contributes to the market through its product TOVIAZ® (fesoterodine fumarate). Approved for the treatment of overactive bladder in adults and neurogenic detrusor overactivity in pediatric patients, TOVIAZ® is available as extended-release tablets in 4 mg and 8 mg strengths. With ongoing updates and rigorous medical review, Pfizer strengthens its presence across major regions by addressing both adult and pediatric incontinence treatment needs.
AbbVie
Astellas Pharma, a global leader in urology, has maintained a strong presence in the market across key regions through its well-established treatments for overactive bladder (OAB) and lower urinary tract symptoms (LUTS) linked to benign prostatic hyperplasia (BPH). With a focus on improving quality of life, Astellas continues to expand its OAB portfolio and awareness initiatives, including annual campaigns and digital tools like OAB.ie, reinforcing its commitment to underserved patient needs.
Merck KGaA
Merck is actively involved in the urinary incontinence drugs market. MSD offers a broad portfolio addressing various types of incontinence, such as oxybutynin, solifenacin, tolterodine, and mirabegron, which target detrusor overactivity. These drugs support the company’s commitment to advancing treatment for overactive bladder and related conditions through evidence-based therapies and global medical outreach.
Kissei Pharmaceutical
Kissei Pharmaceutical Co., Ltd., launched Beova® Tablets 50mg in Japan for the treatment of overactive bladder (OAB), a key segment in the urinary incontinence drugs market. Approved in 2018, Beova®, containing vibegron, is a once-daily β3-adrenergic receptor agonist that effectively reduces urinary urgency, frequency, and urge urinary incontinence. This strategic entry strengthens company’s urology portfolios and contributes to addressing the rising global burden of OAB, particularly in aging populations across major regions.
Other key players in the market are Astellas Pharma, Sanofi S.A., Kyorin Holding, Urovant Sciences, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, and Ferring Pharmaceuticals.
Urinary Incontinence Drugs Market Report Snapshots
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
- Our Insights Store:
-
Industry Statistics
-
Procurement Insights
-
Consumer Insights
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124